{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=formoterol+fumarate+inhalation+solution&page=2", "query": { "intervention": "formoterol fumarate inhalation solution", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 34, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=formoterol+fumarate+inhalation+solution&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=formoterol+fumarate+inhalation+solution&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T18:20:09.915Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03086460", "title": "A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "CHF 1531 pMDI", "type": "DRUG" }, { "name": "Formoterol Inhalation Solution", "type": "DRUG" }, { "name": "Placebo pMDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 67, "start_date": "2017-09-08", "completion_date": "2018-07-28", "has_results": true, "last_update_posted_date": "2021-08-16", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 10, "location_summary": "Tucson, Arizona • Los Angeles, California • Lutherville, Maryland + 7 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lutherville", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03086460" }, { "nct_id": "NCT01854047", "title": "An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "ICS/LABA therapy", "type": "DRUG" }, { "name": "Salbutamol/albuterol", "type": "DRUG" }, { "name": "Levosalbutamol/levalbuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 776, "start_date": "2013-06", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 50, "location_summary": "Fullerton, California • Huntington Beach, California • Los Angeles, California + 38 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01854047" }, { "nct_id": "NCT00691405", "title": "A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Arformoterol tartrate inhalation solution", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 215, "start_date": "2003-10", "completion_date": "2004-05", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 31, "location_summary": "Encinitas, California • Long Beach, California • Brandon, Florida + 28 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Cleawater", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00691405" }, { "nct_id": "NCT00583947", "title": "A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "arformoterol", "type": "DRUG" }, { "name": "levalbuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 53, "start_date": "2008-01", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 14, "location_summary": "Beverly Hills, California • Orange, California • Savannah, Georgia + 10 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Normal", "state": "Illinois" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT00583947" }, { "nct_id": "NCT00685841", "title": "A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Arformoterol tartrate inhalation solution", "type": "DRUG" }, { "name": "Salmeterol MDI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 717, "start_date": "2002-02", "completion_date": "2003-06", "has_results": false, "last_update_posted_date": "2012-11-02", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 52, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Jasper, Alabama + 49 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Oxford", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685841" }, { "nct_id": "NCT00308191", "title": "A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Formoterol Fumarate", "type": "DRUG" }, { "name": "Tiotropium Bromide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 128, "start_date": "2006-04", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2008-03-07", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 17, "location_summary": "Phoenix, Arizona • Los Angeles, California • Sepulveda, California + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sepulveda", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308191" }, { "nct_id": "NCT00424528", "title": "Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Bronchitis", "Emphysema" ], "interventions": [ { "name": "Arformoterol Tartrate Inhalation Solution", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Arformoterol and Tiotropium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 235, "start_date": "2006-12", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2012-06-04", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 28, "location_summary": "Jasper, Alabama • Tucson, Arizona • San Diego, California + 25 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "DeFuniak Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00424528" }, { "nct_id": "NCT00846287", "title": "Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Hyperpolarized Helium-3", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Aformoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Massachusetts, Worcester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 16, "start_date": "2008-11", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-11-01", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00846287" }, { "nct_id": "NCT04320342", "title": "A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD", "COPD Exacerbation" ], "interventions": [ { "name": "Beclomethasone Dipropionate", "type": "DRUG" }, { "name": "Glycopyrronium Bromide", "type": "DRUG" }, { "name": "Formoterol Fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 3406, "start_date": "2022-04-27", "completion_date": "2026-01-12", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 276, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Foley, Alabama + 178 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04320342" }, { "nct_id": "NCT02796651", "title": "Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease - COPD" ], "interventions": [ { "name": "Formoterol fumarate (6 μg)", "type": "DRUG" }, { "name": "Formoterol furmarate (20 μg)", "type": "DRUG" }, { "name": "Placebo for formoterol fumarate", "type": "DRUG" }, { "name": "Formoterol fumarate (12 μg)", "type": "DRUG" }, { "name": "Formoterol fumarate (40 μg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "40 Years to 130 Years" }, "enrollment_count": 132, "start_date": "2016-06-30", "completion_date": "2016-12-07", "has_results": true, "last_update_posted_date": "2018-02-07", "last_synced_at": "2026-09-30T18:20:09.915Z", "location_count": 20, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Tempe, Arizona + 17 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Celebration", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02796651" } ] }